
About
This app enables remote patient monitoring and management for various clinical conditions from home. It displays vital signs from connected devices and facilitates communication between patients and their care teams. Access requires a clinician's prescription and onboarding.
What's New in Biofourmis Care Patient™
26.10
July 1, 2026
Bug fixes.
Events
Developer apps
FAQ
How do I get started with Biofourmis Care Patient?
Access to Biofourmis Care Patient requires a prescription and onboarding from your clinician. They will guide you through the registration process.
What clinical conditions does Biofourmis Care Patient support?
Biofourmis Care Patient supports several clinical conditions, including heart failure, hypertension, and diabetes, spanning acute and post-acute care.
Can I use Biofourmis Care Patient without a clinician's prescription?
No, the app is designed for use under the guidance of a clinician. You must seek advice and a prescription from your clinician to access and use Biofourmis Care Patient.
Does Biofourmis Care Patient make diagnoses?
No, Biofourmis Care Patient is not intended to make any diagnoses or recommendations. You should always seek your clinician's advice before making any medical decisions.
What devices can I connect to Biofourmis Care Patient?
You can connect devices via Bluetooth to automatically display their outputs in the mobile app. The app is currently supported on iPhone.
Where is Biofourmis Care Patient's hardware medically cleared?
The hardware has medical device regulatory clearance in Singapore, Thailand, Malaysia, Australia, the EU, and Hong Kong. Use in other locations is at the user's own risk and responsibility for local law compliance.
How often is Biofourmis Care Patient updated?
The latest version is 26.08, updated on May 14, 2026. Specific update frequency is not detailed, but this indicates ongoing development.
What is the age rating for Biofourmis Care Patient?
Biofourmis Care Patient has an age rating of 17+, indicating it is intended for adult users.








